2011 | Kate McBride | University of Sydney | $50,000
To map p53 pathway mutations in Australian Sarcoma Kindred Study index cases and examine the relationship with outcomes in these patients
2012 | Mary-Anne Young | Peter MacCallum Cancer Centre | $25,000
Research participants’ and healthcare professionals’ views of the feedback of genetic test information following participation in the International Sarcoma Kindred study (ISKS)
2013 | Gillian Mitchell | Peter MacCallum Cancer Centre | $50,000
A pilot surveillance study in Li Fraumeni syndrome
2013 | Damian Myers | St Vincents Melbourne | $25,000
‘Quantum Dots’ with combined structural and functional imaging to investigate osteosarcoma biology and potential therapies.
2014 | Daniel Gough | Monash Institute of Medical Research | $50,000
Defining the role of STAT3 as a tumour suppressor in osteosarcoma
2015 | David Goode | Peter MacCallum Cancer Centre | $50,000
Validating putative novel sarcoma risk genes via targeted DNA sequencing
2016 | Jeremy Hensen | University of New South Wales | $50,000
New drug combination with ATR-CHK1 axis inhibitors for osteosarcoma
2017 | Lucy Coupland | John Curtin School of Medical Research | $50,000
Novel therapies for osteosarcoma: RNA Pol I inhibitors
2018 | Anneke Blackburn | Australian National University | $50,000
Dichloroacetate (DCA) in Osteosarcoma: A non-toxic agent targeting cancer metabolism
2019 | Willem Joost Lesterhuis | Telethon Kids Institute, Centre for Child Health Research, University of Western Australia | $50,000
Local peri-operative immunotherapy for soft tissue sarcoma
2020 | James Blackburn | Garvan Institute of Medical Research | $50,000
Improving fusion gene detection and immune response assessment in sarcoma patients